- Home
- STRO vs AUDC Comparison
STRO vs AUDC Comparison
Compare STRO & AUDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- AUDC
- Stock Information
- Founded
- STRO 2003
- AUDC 1992
- Country
- STRO United States
- AUDC Israel
- Employees
- STRO N/A
- AUDC N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- AUDC Telecommunications Equipment
- Sector
- STRO Health Care
- AUDC Utilities
- Exchange
- STRO Nasdaq
- AUDC Nasdaq
- Market Cap
- STRO 77.7M
- AUDC 282.4M
- IPO Year
- STRO 2018
- AUDC 1999
- Fundamental
- Price
- STRO $0.76
- AUDC $9.30
- Analyst Decision
- STRO Hold
- AUDC Buy
- Analyst Count
- STRO 7
- AUDC 3
- Target Price
- STRO $3.97
- AUDC $11.67
- AVG Volume (30 Days)
- STRO 1.2M
- AUDC 49.7K
- Earning Date
- STRO 08-12-2025
- AUDC 07-29-2025
- Dividend Yield
- STRO N/A
- AUDC 3.73%
- EPS Growth
- STRO N/A
- AUDC 57.57
- EPS
- STRO N/A
- AUDC 0.56
- Revenue
- STRO $66,434,000.00
- AUDC $242,474,000.00
- Revenue This Year
- STRO N/A
- AUDC $1.54
- Revenue Next Year
- STRO N/A
- AUDC $1.41
- P/E Ratio
- STRO N/A
- AUDC $16.57
- Revenue Growth
- STRO N/A
- AUDC N/A
- 52 Week Low
- STRO $0.52
- AUDC $7.70
- 52 Week High
- STRO $5.17
- AUDC $12.72
- Technical
- Relative Strength Index (RSI)
- STRO 49.28
- AUDC 55.77
- Support Level
- STRO $0.73
- AUDC $9.57
- Resistance Level
- STRO $0.83
- AUDC $9.85
- Average True Range (ATR)
- STRO 0.06
- AUDC 0.17
- MACD
- STRO 0.01
- AUDC 0.00
- Stochastic Oscillator
- STRO 61.90
- AUDC 78.87
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About AUDC AudioCodes Ltd.
AudioCodes Ltd develops and sells onverged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.